Clinical Implications of ATRAMI: A Clinician's Perspective

Cardiac Electrophysiology Review

Volumn 2, Issue 1, 1998, Pages 41-43

  Mitrani, Raul D ^a,b   Myerburg, Robert J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Divisions of Pediatric Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013580689     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009942424323     Document Type: Review

References (19)

1. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-1172.
2. Bigger JT, Fleiss JL, Stenman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171.
3. Huikuri HV, Linaluoto MK, Seppanen T, Airaksinen KEJ, Kessler KM, Takkunen JT, Myerburg RJ. Heart rate variability and its circadian rhythm in survivors of cardiac arrest. Am J Cardiol 1992;70:610-615.
4. Huikuri HV, Valkama JO, Airaksinen KEJ, Seppanen T, Kessler KM, Takkunen JT, Myerburg RJ. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87: 1220-1228.
5. Le Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with first myocardial infarction: a prospective study. Circulation 1988;78:816-824.
6. Bigger JT Jr, La Rovere MT, Steinman RC, et al. Comparison of barofreflex senstivity and heart period variability after myocardial infarction. J Am Coll Cardiol 1989;14: 1511-1518.
7. La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators: Baroreflex sensitivity and heart-rate variability in the prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-484.
8. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation 1992;85(suppl I):1-10.
9. Myerburg RJ, Interian A, Mitrani R, Kessler KM Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80(5B):10F-19F.
10. Ryan T, and The Committee on management on acute myocardial infarction. Management of acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-1428.
11. Stanton MS, Tuli MM, Radke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-1526.
12. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990;82: 1095-1105.
13. Mitrani RD, Zipes DP. Clinical neurocardiology: arrhythmias. In Ardell J, ed. Neurocardiology. Oxford University Press, 1994;365-396.
14. Kozlovskis PL, Smets MJD, Duncan RC, Bailey BK, Bassett AL, Myerburg RJ. Regional beta-adrenergic recetpors and adenylate cyclase activity after healing of myocardial infarction in cats. J Moll Cell Cardiol 1990;22:311-322.
15. Huikuri HV, Zaman L, Castellanos A, Kessler KM, Cox M, Gicksman F, Myerburg RJ. Changes in spontaneous sinus node rate as an estimate of cardiac autonomic tone during stable and unstable ventricular tachycardia. J Am Coll Cardiol 1989;13:646-652.
16. Julian DG, Camm AJ, Frangin G, Jane MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349(9053):667-674.
17. Cairns JA, Connolly SJ, Roberts R, Gent M, for the CAMIAT Imvestigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-682.
18. Malik M, Camm AJ, Julian DG, Frangin G Janxe MJ, Schwartz PJ, Simon P, EMIAT investigators. Amiodarone reduces mortality in patients with first myocardial infarction and reduced heart rate variability: retrospective substudy of the EMIAT Trial (Abstract). PACE 1997; 20:1090.
19. Moss AJ, Hall J, Cannon DS, Daubert JP, Higgins SL, Klein H, Levine JH, MADIT investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.